Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/1999
11/30/1999US5994125 A synthetic oligonucleotide; anticoagulant, hypertensive agent, antiinflammatory agent,
11/30/1999US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999US5993859 Pharmaceutical agents
11/30/1999US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999US5993814 Agents for inhibition of chemoattractant
11/30/1999US5993811 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
11/30/1999CA2030795C Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
11/25/1999WO1999060024A1 Methods for amyloid removal using anti-amyloid antibodies
11/25/1999WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999WO1999060015A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999WO1999060012A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999WO1999059997A1 Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
11/25/1999WO1999059992A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
11/25/1999WO1999059980A1 [2-alkyl-5-halogeno-6-(4-trifluoromethylphenyl)-4-pyrimidinylamino]acetamide derivatives, process for producing the same, medicinal composition containing the same, and intermediates for the compounds
11/25/1999WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999WO1999059964A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999WO1999059960A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999WO1999059959A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999WO1999059635A1 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
11/25/1999WO1999059632A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/25/1999WO1999059623A1 Methods and means for preventing or treating inflammation or pruritis
11/25/1999WO1999059617A2 Immunoregulator
11/25/1999WO1999059606A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
11/25/1999WO1999059598A1 Use of tricyclic antidepressants for local analgesia
11/25/1999WO1999059576A1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
11/25/1999WO1999059570A1 Protease inhibitors
11/25/1999WO1999059557A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method
11/25/1999WO1999059526A2 Protease inhibitors
11/25/1999WO1999059524A2 Utilization of aryl(or heteroaryl)azolylcarbinol derivatives in the preparation of a medicament for the treatment of neurogenic inflammation
11/25/1999WO1999048523A3 Antagonists of the inflammatory mediator oncostatin m (osm)
11/25/1999WO1999047545A3 Inhibitors of caspases
11/25/1999WO1999047517A8 Novel heterocyclic compounds
11/25/1999WO1999043344A3 Matrix protein compositions for wound healing
11/25/1999WO1999031969A3 Transgenic animal model for degenerative diseases of cartilage
11/25/1999CA2333310A1 Use of tricyclic antidepressants for local analgesia
11/25/1999CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/25/1999CA2332711A1 Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of neurogenic inflammation
11/25/1999CA2332531A1 Protease inhibitors
11/25/1999CA2332492A1 Protease inhibitors
11/25/1999CA2332462A1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease
11/25/1999CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999CA2332272A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999CA2329130A1 Compositions and methods for non-parenteral delivery of oligonucleotides
11/25/1999CA2328699A1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/25/1999CA2328529A1 Immunoregulator from a human chorionic gonadotropin preparation
11/25/1999CA2328509A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/25/1999CA2328489A1 Secreted proteins and polynucleotides encoding them
11/25/1999CA2327585A1 Use of a cox-2 inhibitor and a nk-1 receptor antagonist for treating inflammation
11/25/1999CA2325600A1 Methods for amyloid removal using anti-amyloid antibodies
11/24/1999EP0959076A1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
11/24/1999EP0959075A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
11/24/1999EP0959074A2 Substituted pyrazoles as CRF antagonists
11/24/1999EP0958833A1 Methods and means for preventing or treating inflammation
11/24/1999EP0958304A1 Nucleotide sequence encoding the cd33-like protein
11/24/1999EP0958287A1 Sulfamide-metalloprotease inhibitors
11/24/1999EP0958282A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
11/24/1999EP0957929A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
11/24/1999EP0957927A1 Medical composition and use thereof for the manufacture of a topical barrier formulation, a uv-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation
11/24/1999EP0957926A1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein
11/24/1999EP0957922A1 New treatment for joint inflammation
11/24/1999EP0957917A1 Vitronectin receptor antagonists
11/24/1999EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999EP0957900A1 Compositions and methods for topical application of therapeutic agents
11/24/1999CN1236354A Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
11/24/1999CN1236317A Stable aspirin ointment preparations
11/24/1999CN1236316A Stable aspirin-containing preparations for external use
11/24/1999CN1235968A Substituted tricyclics
11/24/1999CN1046731C Pyrrolo [2,3-d] pyrimidines and their use
11/24/1999CN1046721C Heterocyclic compounds and their preparation and use
11/24/1999CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
11/23/1999US5990329 Retinoids
11/23/1999US5990326 An antiinflammatory agent as inhibitors of leukotriene hydrolase
11/23/1999US5990282 Receptor protein for human B cell stimulatory factor-2
11/23/1999US5990280 Factor which is heat resistant but sensitive to acidic and alkaline conditions, does not bind heparin, induced by wild type p53 expression, is not thrombospondin, molecular weight of about 100 kilodaltons; diagnosis, anticarcinogenic agents
11/23/1999US5990158 Carboxylic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds
11/23/1999US5990148 Side effect reductions; antiarthritic agents; nonsteroidal antiinflammatory agents
11/23/1999US5990145 Antiinflammatory,-carcinogenic,-tumor,-metastasis agents; cardiovascular disorders, e.g., arteriosclerosis, restenosis; retinopaathies and nephropathies; osteoporosis
11/23/1999US5990142 Antiinflammatory agents and antiallergens having good oral adsorption and bioavailability; cardiotonic and antiischemic agents
11/23/1999US5990116 Trisubstituted phenyl derivatives
11/23/1999US5990109 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
11/23/1999US5990108 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives, preparation thereof, intermediates thereof and drugs containing the same
11/23/1999US5990103 Treating psoriasis by topical adminstration of pentoxifylline and diltiazem to a patient; a combination of a compound having a phosphodiesterase-inhibiting action, and a compound which reduces the intracellular calcium content
11/23/1999US5990102 Substituted azetidin-2-ones for treatment of atherosclerosis
11/23/1999US5990090 A double-stranded dna nf-kappab inhibitor of given nucleotide sequence is effective for the treatment of immune and inflammatory diseases, cancer, and viral infections
11/23/1999US5989863 Human ankyrin family protein
11/23/1999US5989836 Method for measuring the binding sites for macrophage-derived inflammatory mediator (MIP-1α and MIP-1β)
11/23/1999US5989803 Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase
11/23/1999CA1340825C Hyaluronic acid fraction for use as a drug delivery system for medicaments
11/18/1999WO1999058642A2 Secreted proteins and polynucleotides encoding them
11/18/1999WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
11/18/1999WO1999058558A2 Cell signaling proteins
11/18/1999WO1999058555A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
11/18/1999WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058510A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
11/18/1999WO1999058504A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament
1 ... 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 ... 1272